People: AstraZeneca PLC (AZN.L)
13 Dec 2013
Mr. Pascal Soriot has been appointed Chief Executive Officer and Executive Director at AstraZeneca PLC., effective from October 1, 2012. From 2010 to September 2012, he served as Chief Operating Officer of Roche AG’s pharmaceuticals division. Prior to that, he was CEO of Genentech, a biologics business, and led its merger with Roche. He joined the pharmaceutical industry in 1986 and has worked in senior management roles throughout the world in a number of companies since then. He brings to AstraZeneca a breadth of experience in both established and emerging markets, strength of strategic thinking, a track record of managing change and putting strategy into operation, as well as the ability to lead a diverse organisation having lived in Australia, Japan, the US and Europe. He is a doctor of veterinary medicine (École Nationale Vétérinaire d’Alfort, Maisons-Alfort) and holds an MBA from L’Institut Supérieur des Affaires, Jouy-en-Josas.
|Total Annual Compensation, GBP||Long-Term Incentive Plans, GBP||All Other, GBP||Fiscal Year Total, GBP|